至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Resurgent and Gating Pore Currents Induced by De Novo SCN2A Epilepsy Mutations.

eNeuro. 2019; 
Mason ER, Wu F, Patel RR, Xiao Y, Cannon SC, Cummins TR.
Products/Services Used Details Operation
Codon Optimization … Locations of the R853Q and R1882Q mutations are labeled with red stars and red arrows. Materials and Methods. DNA constructs. Codon-optimized human Nav1.2 DNA constructs [wild-type (WT), R1882Q, and R853Q] were designed in-house and synthesized by GenScript Get A Quote

摘要

Over 150 mutations in the SCN2A gene, which encodes the neuronal Nav1.2 protein, have been implicated in human epilepsy cases. Of these, R1882Q and R853Q are two of the most commonly reported mutations. This study utilized voltage-clamp electrophysiology to characterize the biophysical effects of the R1882Q and R853Q mutations on the hNav1.2 channel, including their effects on resurgent current and gating pore current, which are not typically investigated in the study of Nav1.2 channel mutations. HEK cells transiently transfected with DNA encoding either wild-type (WT) or mutant hNav1.2 revealed that the R1882Q mutation induced a gain-of-function phenotype, including slowed fast inactivation, depolarization of ... More

关键词

Nav1.2; channelopathies; epilepsy; gating pore current; resurgent current; whole-cell electrophysiology